Wünsche ich mir nun auch für Gesundheits- und Wohnungskonzerne wie #Fresenius oder #Vonovia!
"So ein Auftreten nach den Belastungen, die deutsche Verbraucher aushalten müssen, ist dreist."
www.tagesschau.de/wirtschaft/e...

Ingo Elfering neuer CIO bei Philips Seit Februar 2026 verantwortet Elfering die IT des niederländischen Healthcare-Tech-Anbieters. Er kommt von Fresenius.

Seit Februar 2026 verantwortet Elfering die IT des niederländischen Healthcare-Tech-Anbieters. Er kommt von Fresenius. www.cio.de/article/4144... #cio #philips #fresenius #itmanager

KI-Spritze für Kliniken: SAP und Fresenius schmieden Millionen-Deal Künstliche Intelligenz soll im Krankenhausalltag die Arbeit von Ärzten und Pflegern erleichtern. Für ein neues Projekt arbeiten nun der Softwareriese und Deutschlands größter Klinikbetreiber zusammen.

Künstliche Intelligenz soll im Krankenhausalltag die Arbeit von Ärzten und Pflegern erleichtern. Für ein neues Projekt arbeiten nun SAP und die Fresenius Group - Deutschlands größter Klinikbetreiber - zusammen. www.cio.de/article/4118... #fresenius #sap #healthcare #AI #klinik

Fresenius Medical Care Boosts EUR 1 Billion Buyback Program with Rapid Execution Fresenius Medical Care accelerates its EUR 1 billion share buyback program, committing to repurchase nearly EUR 415 million worth of shares within months.

Fresenius Medical Care Boosts EUR 1 Billion Buyback Program with Rapid Execution #Germany #share_buyback #Fresenius_Medical_Care #Bad_Homburg #Fresenius

💜Beneficiará a + de 150 profesionales del sector de cuidados renales crónicos

✊ Avanzamos hacia la equidad, la conciliación y la igualdad real.

extremadura.ugt-sp.es/ugt-firma-el...

#UGT #UGTExtremadura #ServiciosPúblicos #PlanDeIgualdad #SanidadPrivada #Fresenius

Death rates at U.S. dialysis clinics among the highest in the industrialized world In Texas, where the number of dialysis centers is higher than in any other state, the I-Team discovered that the problem is especially severe.

Over 1⃣1⃣5⃣0⃣0⃣0⃣safety violations in US dialysis clinics.

2⃣ #Fresenius & #DaVita behind most of them.

😡 Same story: profit before patients.

Laptop with title slide "Seuchen wir wie Hühner?"

Do we search like 🐔🐔🐔?
In a "meet the prof" event I introduced our new students at Charlotte #Fresenius Uni of Psych in #cologne to the really important questions of General #Psychology! Including some @icevislab.bsky.social -style foraging!

Fresenius raises full-year revenue guidance after strong Q2 results Investing.com -- German healthcare group Fresenius SE (ETR:FREG) on Wednesday raised its full-year revenue guidance following strong second-quarter results driven by growth in its Kabi division and solid performance in its Helios hospital unit. The company now expects organic revenue growth of 5-7% for fiscal year 2025, up from its previous forecast of 4-6%, while maintaining its adjusted EBIT growth target of 3-7% at constant exchange rates. Fresenius reported second-quarter revenue of €5,571 million with organic growth of approximately 5%, slightly below consensus estimates of €5,618 million. Adjusted EBIT remained stable at constant exchange rates, with a margin of 11.7%, exceeding analyst expectations of 11.4%. The Kabi division, which specializes in clinical nutrition, pharmaceuticals and medical technologies, delivered 6% organic revenue growth in the quarter. Growth vectors within Kabi increased by 7%, with particularly strong performance in Biopharma, which grew 33% organically, benefiting from biosimilar launches including Tyenne and Conexxence. Kabi’s EBIT margin expanded to 16.4%, driven by cost savings that offset transaction exchange effects and nutrition headwinds in China. The company maintained Kabi’s full-year organic growth forecast in the mid to high single digits, with an adjusted EBIT margin target of 16-16.5%. The Helios hospital division posted 5% organic revenue growth, with Germany delivering 6% organic growth while Spain grew at 3%, impacted by the Easter holiday falling in the second quarter this year versus the first quarter last year. Despite a 5% decline in EBIT due to the phasing out of energy relief funds in Germany, Helios maintained a 10% EBIT margin, supported by strong profitability in Spain. Fresenius also announced plans to sell shares in Fresenius Medical Care (ETR:FMEG) on a pro rata basis following FME’s share buyback announcement, while maintaining its current stake of approximately 28.6%. The company’s net debt to EBITDA ratio stands at 3.1x, slightly above its target corridor of 2.5x-3.0x, which it attributed to the resumption of dividend payments. Strong free cash flow contributed to 8% growth in core earnings per share, supported by lower interest expenses. This article was generated with the support of AI and reviewed by an editor. For more information see our T&C. With valuations skyrocketing in 2024, many investors are uneasy putting more money into stocks. Sure, there are always opportunities in the stock market – but finding them feels more difficult now than a year ago. Unsure where to invest next? One of the best ways to discover new high-potential opportunities is to look at the top performing portfolios this year. ProPicks AI offers 6 model portfolios from Investing.com which identify the best stocks for investors to buy right now. For example, ProPicks AI found 9 overlooked stocks that jumped over 25% this year alone. The new stocks that made the monthly cut could yield enormous returns in the coming years. Is FREG one of them?

Click Subscribe #Fresenius #EarningsReport #Q2Results #RevenueGuidance #StockMarket

Fresenius raises full-year revenue guidance after strong Q2 results Investing.com -- German healthcare group Fresenius SE (ETR:FREG) on Wednesday raised its full-year revenue guidance following strong second-quarter results driven by growth in its Kabi division and solid performance in its Helios hospital unit. The company now expects organic revenue growth of 5-7% for fiscal year 2025, up from its previous forecast of 4-6%, while maintaining its adjusted EBIT growth target of 3-7% at constant exchange rates. Fresenius reported second-quarter revenue of €5,571 million with organic growth of approximately 5%, slightly below consensus estimates of €5,618 million. Adjusted EBIT remained stable at constant exchange rates, with a margin of 11.7%, exceeding analyst expectations of 11.4%. The Kabi division, which specializes in clinical nutrition, pharmaceuticals and medical technologies, delivered 6% organic revenue growth in the quarter. Growth vectors within Kabi increased by 7%, with particularly strong performance in Biopharma, which grew 33% organically, benefiting from biosimilar launches including Tyenne and Conexxence. Kabi’s EBIT margin expanded to 16.4%, driven by cost savings that offset transaction exchange effects and nutrition headwinds in China. The company maintained Kabi’s full-year organic growth forecast in the mid to high single digits, with an adjusted EBIT margin target of 16-16.5%. The Helios hospital division posted 5% organic revenue growth, with Germany delivering 6% organic growth while Spain grew at 3%, impacted by the Easter holiday falling in the second quarter this year versus the first quarter last year. Despite a 5% decline in EBIT due to the phasing out of energy relief funds in Germany, Helios maintained a 10% EBIT margin, supported by strong profitability in Spain. Fresenius also announced plans to sell shares in Fresenius Medical Care (ETR:FMEG) on a pro rata basis following FME’s share buyback announcement, while maintaining its current stake of approximately 28.6%. The company’s net debt to EBITDA ratio stands at 3.1x, slightly above its target corridor of 2.5x-3.0x, which it attributed to the resumption of dividend payments. Strong free cash flow contributed to 8% growth in core earnings per share, supported by lower interest expenses. This article was generated with the support of AI and reviewed by an editor. For more information see our T&C. Before you buy stock in FREG, consider this: ProPicks AI are 6 easy-to-follow model portfolios created by Investing.com for building wealth by identifying winning stocks and letting them run. Over 150,000 paying members trust ProPicks to find new stocks to buy – driven by AI. The ProPicks AI algorithm has just identified the best stocks for investors to buy now. The stocks that made the cut could produce enormous returns in the coming years. Is FREG one of them?

Click Subscribe #Fresenius #Healthcare #Investing #RevenueGrowth #Q2Results

Frenova and Nephronomics Unite to Elevate Kidney Disease Treatment with Genomics Innovation Fresenius Medical Care's Frenova collaborates with Nephronomics and GENEWIZ to enhance genomic analysis, aiming for breakthroughs in precision kidney disease care.

Frenova and Nephronomics Unite to Elevate Kidney Disease Treatment with Genomics Innovation #Germany #Bad_Homburg #Fresenius #Frenova #Nephronomics

Careers at Fresenius Medical Care | Join Our Mission Improve lives with a career at Fresenius Medical Care. Join a global leader in dialysis care and innovative health solutions.

Welcome to Virginia Career Works - Capital's Career Corner!

Fresenius Medical Care is Hiring! 🎉

⭐Front Desk
⭐RN
⭐PCT
AND MORE! APPLY TODAY!

jobs.freseniusmedicalcare.com?location_nam...

#CareerCorner #Fresenius #VirginiaCareerWorks #VCWCapital #RVA #Careers #Hiring #Jobs #RVAJobs #CareerSky #RN

In the #USA, we have the least effective, most expensive #Dialysis care in the developed world & our patients suffer a 50% higher mortality rate.

In #CA, we've tried 4 times in 10 years to regulate #Fresenius, #DaVita, & others. They spent billions successfully to stop us.

youtu.be/ioJ0xb3w8nY?...

Fresenius Medical Care Partners with Mexican Health Authorities to Enhance Dialysis Access Fresenius Medical Care collaborates with Mexican health authorities to broaden access to innovative High-Volume Hemodiafiltration therapy for patients with kidney diseases in Mexico. This initiative aims to improve treatment and quality of life.

Fresenius Medical Care Partners with Mexican Health Authorities to Enhance Dialysis Access #Mexico #Mexico_City #Hemodiafiltration #Fresenius #CCINSHAE

¿Cómo llega el dinero del gasto sanitario público a la sanidad privada? Quirón, Fresenius y el DAX 30 La debilidad presupuestaria del sistema sanitario público y especialmente del gasto en personal y en atención primaria, son las causas estructurales que explican la rentabilidad de la inversión en la ...

🔴Cómo llega el dinero del #GastoSanitario público a la #SanidadPrivada: #Quirón #Fresenius y #DAX30

#DerogaciónLey15/97
#RecuperaTuSanidad✊🏼
#SanidadPública🤍

#OrganizaciónCriminal
#PatriotasDePulserita
#PolíticosTramposos
#StopCorrupción
#AdnCorrupto
#PpMafia🇪🇦🤮

www.diario-red.com/opinion/remi...

¿Cómo llega el dinero del gasto sanitario público a la sanidad privada? Quirón, Fresenius y el DAX 30 La debilidad presupuestaria del sistema sanitario público y especialmente del gasto en personal y en atención primaria, son las causas estructurales que explican la rentabilidad de la inversión en la ...

¿Cómo llega el dinero del #gastosanitariopúblico a la #sanidadprivada? #Quirón, #Fresenius y el #DAX30
diared.org/3RYwueA

Fresenius Health Services Betriebstechnik-Nord GmbH: Psychoterror, Abmahnungen und Hausbesuche bei (unbefristet) Streikenden statt Tarifvertrag » LabourNet Germany "Fresenius eskaliert im Tarifkonflikt – ver.di weitet Arbeitskämpfe aus und prüft Strafanzeige: Die Vereinte Dienstleistungsgewerkschaft ver.di Nord weitet die Arbeitskämpfe bei der Fresenius Health S...

#Fresenius Health Services Betriebstechnik-Nord GmbH: Psychoterror, Abmahnungen und Hausbesuche bei (unbefristet) Streikenden statt Tarifvertrag

Psychischer Druck bei Streikbeteiligung: Gewerkschaft Ver.di erhebt massive Vorwürfe gegen Klinikdienstleister Unbefristeter Streik geht in neue Runde. Ver.di will den Beschäftigten auch für die komplette kommende Woche einen Streikaufruf zukommen lassen.

„Laut [Ver.di] wurden arbeitsrechtliche Maßnahmen angedroht, wenn man sich am Streik beteiligt und es soll Hausbesuche bei den Beschäftigten durchgeführt worden sein.“

#Arbeitskampf #SH #Fresenius

Fresenius in Bad Homburg verkauft Projektgeschäft Der Medizinkonzern Fresenius verkauft das internationale Projektgeschäft seiner früheren Beteiligungsgesellschaft Vamed an das deutsche Gesundheitsunternehmen Worldwide Hospital Group.

#Fresenius in #BadHomburg verkauft Projektgeschäft #Vamed www.hessenschau.de/wirtschaft/f...

E-Novations au service du patient en #dialyse #péritonéale : n’hésitez pas à nous rejoindre pour ce #webinar #Fresenius #Medical #Care ce vendredi 13.00

Fresenius shares up by 1.71%! 📈 A positive move for the healthcare giant, showing strength in its sector today! 🏥
#stockmarket #DAX40 #Fresenius #investing 💹

| FSE

Bei der nachhaltigen Transformation hat #Fresenius Nachholbedarf. Auf der #Hauptversammlung von Fresenius fragen wir: Will Fresenius sich ein vollständiges Klimaziel setzen, das auch Scope 3 konkret berücksichtigt? Wenn ja, bis wann soll das erfolgen?
www.fresenius.com/de/hauptvers...

| FSE

#Vamed, das Sorgenkind von #Fresenius, wird zum Großteil verkauft. Auf der #Hauptversammlung von Fresenius wollen wir wissen, warum dabei so hohe Sonderaufwendungen und Wertberichtigungen anfallen. Hat das Risikomanagement versagt?
www.fresenius.com/de/hauptvers...

Collage aus 4 Fotos. Auf dem Boden liegen offene Laptoptaschen mit teils schon ausgepackten Laptops. Ein Mann sortiert Unterlagen. Auf 2 weiteren Fotos sitzen eine Dame aus Namibia und von der Hochschule Düsseldorf an einem Tisch. Auf dem Tisch 2 Laptops in einer Laptoptasche. Die Professoerin aus Düsseldorf erklärt Lernsoftware, Lerninhalte und Konzept. EIn weiteres Foto zeigt einen Klassenraum mit Grundschülern. Vor der Klasse stehen 2 namibische Lehrerinnen und eine Frau aus Düsseldorf.

Petry Knyrim, HS #Fresenius #Düsseldorf berichtet:
"Wir haben einen Raum nahe der #Grundschule in #Kalkfeld, #Namibia angemietet. Betreuer haben sich in das Lernmaterial eingearbeitet und bauen nun Angebote für 90 Schüler*innen auf."
platform.labdoo.org/de/edoovilla...
#labdoo #hochschule #flugpate

#Fresenius hat knapp 10% verloren, weil Anleger glauben, dass deren Produkte aufgrund Abnehmspritzen von #Novartis und Co. nicht mehr so viel gebraucht werden.

Hat von denen keiner Verstanden, dass Abnehmspritzen keine langfristige Lösung zur Gewichtsreduktion sind?

#Fresenius wird weiterhin Unterstützung der Bundesregierung i.H.v. bis zu €300Mio erhalten. Dadurch ist es Fresenius jedoch weiterhin untersagt, Dividenden für das Jahr 2023 auszuschütten

Können wir #Krankenhäuser bitte wieder verstaatlichen?

Private Träger verdienen sich eine goldene Nase mit selektiver Gesundheitsfürsorge. Dies muss aufhören.

Hört auf, mit unserer Gesundheit zu spielen!

#KPlusGruppe #Helios #Asklepios #Sana #Fresenius #Paracelsus #Ameos https://t.co/TnTFKPIxYB